US Broker Ratings

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring a 39% Potential Upside in the Medical Instruments Sector

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, is capturing investor attention with its..

CVS Health Corporation (CVS) Stock Analysis: Evaluating an 18% Potential Upside Amid Strong Buy Ratings

CVS Health Corporation (NYSE: CVS), a titan in the healthcare sector, continues to captivate investors with its expansive reach and robust market presence. With a current..

Waystar Holding Corp. (WAY) Stock Analysis: Unlocking a 54% Potential Upside

For investors keen on exploring opportunities in the healthcare sector, Waystar Holding Corp. (NASDAQ: WAY) presents a compelling case with a striking potential upside of 54.13%...

Illumina, Inc. (ILMN) Stock Analysis: Can This Genomics Leader Defy Its Potential Downside?

Illumina, Inc. (NASDAQ: ILMN) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in San Diego, California, Illumina’s core..

Bruker Corporation (BRKR) Stock Report: Assessing the 8.83% Potential Upside for Investors

Bruker Corporation (NASDAQ: BRKR) is a key player in the healthcare sector, specifically within the medical devices industry, offering a rich portfolio of scientific instruments and..

Corcept Therapeutics (CORT) Stock Analysis: A Biotech Innovator with 138% Potential Upside

Corcept Therapeutics Incorporated (NASDAQ: CORT) is making waves in the biotechnology sector, presenting a compelling opportunity for investors with a notable potential upside of 138.22%. With..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Assessing the 14% Potential Upside in the Medical Devices Sector

Bio-Rad Laboratories, Inc. (NYSE: BIO) stands as a distinguished player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $8.23..

Teleflex Incorporated (TFX) Stock Analysis: Navigating Healthcare Market with 7.84% Potential Upside

Teleflex Incorporated (NYSE: TFX) stands at the crossroads of innovation and opportunity within the healthcare sector, with its latest stock analysis revealing a potential upside of..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Healthcare Distribution with Steady Growth

As an investor in the healthcare sector, understanding the dynamics of companies like Henry Schein, Inc. (NASDAQ: HSIC) is crucial for building a diversified portfolio. With..

Encompass Health Corporation (EHC) Stock Analysis: Unpacking a 31.93% Potential Upside

Encompass Health Corporation (NYSE: EHC) has captured the attention of investors with its robust growth prospects and substantial potential upside. Operating in the healthcare sector, EHC..

Roivant Sciences Ltd. (ROIV) Stock Analysis: A 19% Potential Upside in the Biotech Innovator

Roivant Sciences Ltd. (NASDAQ: ROIV), a London-based clinical-stage biopharmaceutical company, is increasingly capturing investor attention with its innovative approach to drug discovery and development. The company,..

Revvity, Inc. (RVTY) Stock Analysis: Potential 16.53% Upside in Healthcare Diagnostics

Revvity, Inc. (NYSE: RVTY), a key player in the healthcare sector, specifically within the diagnostics and research industry, presents a compelling opportunity for investors seeking to..

Globus Medical, Inc. (GMED) Stock Analysis: A Promising 13% Upside in the Medical Device Sector

Globus Medical, Inc. (NYSE: GMED) stands as a formidable player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $11.79..

Charles River Laboratories (CRL) Stock Analysis: Navigating a Challenging Landscape with Innovation and Strategic Alliances

Charles River Laboratories International, Inc. (NYSE: CRL) remains a pivotal player in the healthcare sector, particularly within diagnostics and research. With a market capitalization of $9.96..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unpacking a Promising 10.64% Upside in the Biotech Sector

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a burgeoning player in the healthcare sector, is making waves in the biotechnology industry. With a market capitalization of $15.08 billion,..

Quest Diagnostics (DGX) Stock Analysis: Potential 13.97% Upside Captures Investor Attention

Quest Diagnostics Incorporated (NYSE: DGX), a significant player in the healthcare sector, stands out with a market capitalization of $19.43 billion. This diagnostic and research titan,..

Exact Sciences Corporation (EXAS) Stock Analysis: Unveiling Growth Potential in Cancer Diagnostics

Exact Sciences Corporation (NASDAQ: EXAS), a pivotal player in the healthcare sector, is making waves in the diagnostics and research industry with its innovative cancer screening..

Repligen Corporation (RGEN): Investor Outlook with a 15% Upside Potential in the Bioprocessing Sector

Repligen Corporation (NASDAQ: RGEN), a prominent player in the life sciences sector, is capturing investor attention with its promising growth trajectory and a potential upside of..

Universal Health Services, Inc. (UHS) Stock Analysis: Potential Upside Amid Solid Performance Metrics

Universal Health Services, Inc. (NYSE: UHS), a prominent player in the healthcare sector, operates an extensive network of acute care and behavioral health facilities across the..

Abbott Laboratories (ABT) Stock Analysis: Exploring the 16.52% Potential Upside

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, continues to capture investor attention with its robust market presence and promising growth metrics. As a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds